证实在新生儿中使用人口药动力学方法与截止样本持续时间的珍塔米辛剂量策略的适用性
Bonifasius Siyuka Singu1, Roger Karel Verbeeck1, Clarissa Hildegard Pieper2
1School of Pharmacy, Faculty of Health Sciences & Veterinary Medicine, University of Namibia, Windhoek Private Bag 13301, Namibia.
Children (Basel, Switzerland)
|August 29, 2024
概括
这项研究发现,对于新生儿来说,每24小时服用5毫克/千克的 جنت米辛剂量是适当的. 这种疗法有助于达到安全有效的 gentamicin 度,同时考虑出生体重和产后年龄等因素.
科学领域:
- 新生儿药理学 新生儿药理学
- 儿科的药理动力学 儿科的药理动力学
- 优化抗生素剂量的优化
背景情况:
- 甘胺是新生儿感染的关键抗生素,但具有毒性和耳毒性风险.
- 目前针对新生儿的珍塔米辛剂量指南可能无法始终防止有毒药物度.
- 新生儿群体表现出独特的药物动力学特征,影响药物的有效性和安全性.
研究的目的:
- 评估新生儿每24小时服用5毫克/千克珍塔米辛剂量方案的适当性.
- 评估出生体重和产后年龄对新生儿 gentamicin 药理动学的影响.
- 模拟 gentamicin 度,并将其与已确定的安全有效水平进行比较.
主要方法:
- 一项前性观察性研究,涉及纳米比亚52名新生儿.
- 每24小时服用5毫克/千克的 جنت米辛,与青素或安培素结合使用.
- 使用截断的药理动力学采样计划收集血液样本进行分析.
- 采用一段线性药理动力学模型来分析数据.
主要成果:
- 出生体重,产后年龄和白细胞计数是 جنت米辛清除 (CL) 的显著预测因素.
- 出生体重被确定为 جنت米辛分布量 (V) 的关键预测因素.
- 模拟的 جنت米辛度显示出受产后年龄和体重影响的变化.
结论:
- 5毫克/公斤/24小时的 جنت米辛剂量方案被证实适用于新生儿.
- 这种剂量策略产生了与以前报告的安全有效水平相一致的模拟 gentamicin 度.
- 这些发现支持使用这种 gentamicin 治疗方案,考虑到个体新生儿的特征,如年龄和出生体重.
相关概念视频
Analysis of Population Pharmacokinetic Data
240
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
240
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
78
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
78
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51
Nonlinear Pharmacokinetics: Overview
313
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
313
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
432
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
432


